ADRB3 and non-small cell lung carcinoma: Furthermore, we found that Ki-67 expression in ADRB3+ monocytes increased significantly in NSCLC compared with healthy control (MFI 15.5 ± 2.3 versus 1.7 ± 0.2, P < 0.01, Fig. 3g–i).